...
首页> 外文期刊>Journal of cardiac surgery. >Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device‐related methicillin‐susceptible Staphylococcus aureus bacteremia
【24h】

Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device‐related methicillin‐susceptible Staphylococcus aureus bacteremia

机译:Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device‐related methicillin‐susceptible Staphylococcus aureus bacteremia

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract There is an increasing use of left ventricular assist devices (LVADs) as bridge to transplantation or permanent destination therapy in the heart failure patient population. Infection remains a common complication in LVADs, with Gram‐positive skin flora as predominant pathogens implicated, including Staphylococcus aureus. While there is emerging evidence for synergistic antibiotic combinations with methicillin resistant S. aureus, there remains a significant gap in the literature for persistent methicillin susceptible S. aureus bacteremia. In this article, we describe the first successful treatment of persistent LVAD‐related bacteremia with salvage oxacillin plus ertapenem. The salvage therapy described here must be balanced by the risks for toxicity, impact on resistance, microbiota disruption, drug shortages, and patient costs. This combination warrants further evaluation in the clinical setting to better establish its role in our expanding patient population.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号